Platelet count at term pregnancy: A reappraisal of the threshold

被引:142
作者
Boehlen, F
Hohlfeld, P
Extermann, P
Perneger, TV
De Moerloose, P
机构
[1] Univ Hosp Geneva, Dept Internal Med, Div Angiol & Haemostasis, Geneva, Switzerland
[2] Univ Lausanne Hosp, Dept Gynecol & Obstet, Lausanne, Switzerland
[3] Univ Hosp Geneva, Dept Gynecol & Obstet, Geneva, Switzerland
[4] Inst Social & Prevent Med, Geneva, Switzerland
[5] Qual Care Unit, Geneva, Switzerland
关键词
D O I
10.1016/S0029-7844(99)00537-2
中图分类号
R71 [妇产科学];
学科分类号
100211 [妇产科学];
摘要
Objective: To assess the safety of a new platelet count threshold for the definition of maternal thrombocytopenia late in pregnancy. Methods: A platelet count was performed in 6770 pregnant women late in pregnancy and in 6103 of their newborns as well as in a control group of 287 age-matched nonpregnant healthy women. Results: The prevalence of maternal thrombocytopenia (platelet count less than 150 x 10(9)/L) was 11.6%. The mean platelet counts (248 compared with 213 x 10(9)/L) and 2.5th percentile (164 compared with 116 x 10(9)/L) were significantly higher in healthy nonpregnant women than in pregnant women. Among thrombocytopenic pregnant women, 621 (79%) had platelet counts between 116 and 149 x 10(9)/L; none (0%; 95% confidence interval 0, 0.6) had complications related to thrombocytopenia, and none of their newborns had severe thrombocytopenia (platelet count less than 20 x 10(9)/L). Conclusion: In healthy pregnant women, a platelet count over 115 x 10(9)/L. late in pregnancy does not require further investigation during pregnancy and may be considered a safe threshold. (Obstet Gynecol 2000;95:29-33. (C) 2000 by The American College of Obstetricians and Gynecologists.).
引用
收藏
页码:29 / 33
页数:5
相关论文
共 32 条
[1]
RETROSPECTIVE ANALYSIS OF PLATELET NUMBERS AND VOLUMES IN NORMAL-PREGNANCY AND IN PREECLAMPSIA [J].
AHMED, Y ;
VANIDDEKINGE, B ;
PAUL, C ;
SULLIVAN, MHF ;
ELDER, MG .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1993, 100 (03) :216-220
[2]
Pregnancy-associated thrombocytopenia revisited: Assessment and follow-up of 50 cases [J].
Ajzenberg, N ;
Dreyfus, M ;
Kaplan, C ;
Yvart, J ;
Weill, B ;
Tchernia, G .
BLOOD, 1998, 92 (12) :4573-4580
[3]
PLATELET SIZE IN HEALTH AND HEMATOLOGIC DISEASE [J].
BESSMAN, JD ;
WILLIAMS, LJ ;
GILMER, PR .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1982, 78 (02) :150-153
[4]
Maternal antiplatelet antibodies in predicting risk of neonatal thrombocytopenia [J].
Boehlen, F ;
Hohlfeld, P ;
Extermann, P ;
De Moerloose, P .
OBSTETRICS AND GYNECOLOGY, 1999, 93 (02) :169-173
[5]
COAGULATION AND FIBRINOLYTIC SYSTEMS IN PRE-ECLAMPSIA AND ECLAMPSIA [J].
BONNAR, J ;
MCNICOL, GP ;
DOUGLAS, AS .
BRITISH MEDICAL JOURNAL, 1971, 2 (5752) :12-&
[6]
THROMBOCYTOPENIA AT DELIVERY - A PROSPECTIVE SURVEY OF 6715 DELIVERIES [J].
BURROWS, RF ;
KELTON, JG .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 162 (03) :731-734
[7]
INCIDENTALLY DETECTED THROMBOCYTOPENIA IN HEALTHY MOTHERS AND THEIR INFANTS [J].
BURROWS, RF ;
KELTON, JG .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (03) :142-145
[8]
FETAL THROMBOCYTOPENIA AND ITS RELATION TO MATERNAL THROMBOCYTOPENIA [J].
BURROWS, RF ;
KELTON, JG .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (20) :1463-1466
[9]
CONOVER WJ, 1980, PRACTICAL NONPARAMET, P111
[10]
COOK RL, 1991, OBSTET GYNECOL, V78, P578